Clinical Trial Update: BPL-003 Efficacy and Safety in Treatment Resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BPL-003 for treatment-resistant depression has completed, reporting efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• BPL-003

Snippet

Sponsor: Beckley Psytech Limited | Conditions: Treatment Resistant Depression | Phase 2 | Status: COMPLETED